Regenerative MedicineGene and Optogenetic Therapies Are Transforming Inherited Blindness Treatment
Inherited retinal degenerations are a heterogeneous group of genetic disorders causing progressive, often severe vision loss. Hundreds of disease-causing gene variants have now been identified, reflecting the extraordinary complexity of the retina's development and maintenance. This Lancet review from University of Pennsylvania researchers synthesizes the clinical landscape — categorizing diseases by which retinal cell type is primarily affected — and surveys an exciting wave of emerging treatments. These include gene therapy (replacing or silencing faulty genes), cell-based approaches (transplanting functional cells), optogenetics (using light-sensitive proteins to restore vision), and implantable retinal chips. The authors emphasize that early referral to specialized eye care is critical, as timely diagnosis enables access to these rapidly evolving interventions and may preserve more functional vision before irreversible cell loss occurs.
